1.
Kumar S, Singh A, Singh N, Faizi AI, Mishra BK, Gupta A, et al. A Real World Analysis of Safety and Efficacy of Nilotinib when Used as First Line and Beyond: Retrospective Single Centre Study Representing Largest Cohort of Indian Patients Treated with Nilotinib. Asian Pac J Cancer Biol [Internet]. 2024 May 14 [cited 2026 Jun. 4];9(2):137-4. Available from: http://waocp.com/journal/index.php/apjcb/article/view/1313